Carrier | Cargo | Function | Diseases | References |
---|---|---|---|---|
Liposome | siRNA | Inhibiting monocyte production and egression in the bone marrow | Atherosclerosis, myocardial infarction, pancreatic islet transplantation in diabetes | [29] |
L-glutamic acid, N-(3-carboxy-1-oxopropyl)-, 1,5-dihexadecyl ester modified liposome | – | Bone marrow accumulation | – | [31] |
EGFP-EGF1-conjugated PLGA NPs | shRNA | Modulating macrophage recruitment | Atherosclerosis | [38] |
Lipid–polymer NPs | siRNA | Modulating monocyte recruitment | Myocardial infarction | [39] |
PLGA NPs | Irbesartan | Modulating monocyte recruitment | Myocardial ischemia–reperfusion injury | [40] |
7C1 NPs | siRNA | Modulating monocyte recruitment | Myocardial infarction | [42] |
α-gal nanoparticles | – | Modulating macrophage recruitment | Myocardial infarction | [44] |
α-gal nanoparticles | – | Modulating macrophage recruitment | Diabetic wound | [45] |
Liposomes | Clodronate | Macrophage depletion | Endometriosis | [52] |
Liposomes | Clodronate | Macrophage depletion | Rheumatoid arthritis | [53] |
Liposomes | Clodronate | Macrophage depletion | Rheumatoid arthritis | [54] |
Dendrimer | Methotrexate | Macrophage depletion, anti-inflammation | Rheumatoid arthritis | [56] |
Reconstituted high-density lipoprotein NPs | Statins | Inhibiting macrophage proliferation | Atherosclerosis | |
Mesoporous silica NPs | IL-4 | Modulating macrophage polarization | – | [62] |
Gold NPs | – | Modulating macrophage polarization | Bacterial sepsis | [63] |
Hyaluronic acid-poly(ethyleneimine) (HA-PEI) NPs | IL-4/IL-10 expressing plasmid DNA | Modulating macrophage polarization | LPS-induced inflammation | [64] |
HA-PEI NPs | MicroRNA-223 | Modulating macrophage polarization | LPS-induced inflammation | [65] |
Graphene oxide NPs | IL-4 expressing plasmid DNA | Modulating macrophage polarization | Myocardial infarction | [66] |
Macrophage plasma membrane coated liposomes | Dexamethasone | Selective targeting inflamed tissues | Phlogosis | [69] |
Macrophage cell membrane coated PLGA NPs | – | Neutralize endotoxins and proinflammatory cytokines | Sepsis | [79] |
Polyion complex NPs | Catalase | Anti-inflammation and improving neuroprotective ability | Parkinson's disease | [73] |
Iron oxide NPs | – | Monocyte imaging with MRI | Cutaneous inflammation | [75] |
Poly(lactide-coglycolide) NPs | – | Modulating macrophage polarization | Spinal cord injury | [80] |